As of 2025, retatrutide has not received marketing authorisation from the MHRA or EMA and is not available as a licensed treatment in the UK through the NHS or via private prescribing
Given the functional detriment that would arise from the reduced myocardial capacity to translate cellular respiration into ATP, we again drew on KEGG-facilitated pathway analysis
Starting anything can feel intimidating, but starting is how you take back control
The benefits beyond weight loss that apply to dual and triple agonists include improved sleep quality, reduced inflammation, better cardiovascular function, and enhanced insulin sensitivity
The Times reported in February that doctors are already wrestling with patients who hit every metabolic target and want to keep going
So, regulators have been dubious about telehealth companies' claims that, in the case of Hims & Hers, nearly half a million patients need custom doses